Sylvester Comprehensive Cancer Center

  • 20160793 - Barredo Julio

  • Investigator:
    Julio Barredo
    RCname Email

    		Coordinator:
    RCemailImg Eva Pavicic
    RCphone +1 (305) 2437846

    IRB: 20160793

    		SDG: Pediatric Cancer
    Disease Site(s):

    Soft Tissue
    Sponsor: Moffitt Cancer Center

    Enrolling Sites:

    JMH
    Sylvester
    Title:

    Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
    Eligibility Criteria - NCT02945800 *This information has been extracted from " www.clinicaltrials.gov"

  • ARST1431 - Barredo, Julio

  • Investigator:
    Julio Barredo
    RCname Email

    		Coordinator:
    RCemailImg Nuria Garantiva
    RCphone +1 (786) 2743477

    IRB: 20170069

    		SDG: Pediatric Cancer
    Disease Site(s):

    Soft Tissue
    Sponsor: COG

    Enrolling Sites:

    JMH
    Sylvester
    Title:

    ARST1431: A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
    Eligibility Criteria - NCT02567435 *This information has been extracted from " www.clinicaltrials.gov"

  • 19487 - Barredo, Julio

  • Investigator:
    Julio Barredo
    RCname Email

    		Coordinator:
    RCemailImg Eva Pavicic
    RCphone +1 (305) 2437846

    IRB: 20181082

    		SDG: Pediatric Cancer
    Disease Site(s):

    Bones and Joints
    Sponsor: Moffitt Cancer Center

    Enrolling Sites:

    JMH
    Sylvester
    Title:

    19487: A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma
    Eligibility Criteria - NCT03628209 *This information has been extracted from " www.clinicaltrials.gov"

  • TAPUR - Calfa, Carmen

  • Investigator:
    Carmen Calfa
    RCname Email

    		Coordinator:
    RCemailImg Carolina Troche
    RCphone +1 (305) 2431481

    IRB: 20170529

    		SDG: Breast Cancer
    Disease Site(s):

    Breast,Prostate,Kidney,Non-Hodgkin Lymphoma,Multiple Myeloma,Lymphoid Leukemia,Colon,Liver,Pancreas,Larynx,Soft Tissue,Kaposis sarcoma,Multiple
    Sponsor: ASCO

    Enrolling Sites:

    Deerfield
    Gables
    Kendall
    Plantation
    Sylvester
    Title:

    The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Eligibility Criteria - NCT02693535 *This information has been extracted from " www.clinicaltrials.gov"

  • 20201132 - D'Amato Gina

  • Investigator:
    Gina D'Amato
    RCname Email

    		Coordinator:
    RCemailImg Mirna Gonzalez
    RCphone +1 (305) 2432441

    IRB: 20201132

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Soft Tissue
    Sponsor: Tracon

    Enrolling Sites:

    Sylvester
    Title:

    A Pivotal Trial Of Envafolimab, And Envafolimab In Combination With Ipilimumab, In Patients With Advanced Or Metastatic Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma Who Have Progressed On Prior Chemotherapy
    Eligibility Criteria - NCT04480502 *This information has been extracted from " www.clinicaltrials.gov"

  • MATCH - Huang, Marilyn

  • Investigator:
    Marilyn Huang
    RCname Email

    		Coordinator:
    RCemailImg Carolina Troche
    RCphone +1 (305) 2431481

    IRB: 20150671

    		SDG: Gynecologic Cancer
    Disease Site(s):

    Cervix Uteri,Corpus Uteri,Ovary,Other Female Genital,Prostate,Kidney,Non-Hodgkin Lymphoma,Multiple Myeloma,Colon,Liver,Pancreas,Larynx,Soft Tissue,Kaposis sarcoma
    Sponsor: ECOG

    Enrolling Sites:

    Coral Springs
    Deerfield
    Gables
    Hollywood
    Kendall
    Plantation
    Sylvester
    Title:

    Molecular Analysis for Therapy Choice (MATCH EAY131)
    Eligibility Criteria - NCT02465060 *This information has been extracted from " www.clinicaltrials.gov"

  • VYR-VSV2-101 - Merchan, Jaime

  • Investigator:
    Jaime Merchan
    RCname Email

    		Coordinator:
    RCemailImg Rakhi Modak
    RCphone +1 (305) 2437387

    IRB: 20170023

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Lung,Melanoma, skin,Kaposis sarcoma
    Sponsor: VYRIAD

    Enrolling Sites:

    Sylvester
    Title:

    Phase I Trial of Intratumoral Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and human interferon beta (VSV-IFNß-NIS), in Patients with Refractory Solid Tumors
    Eligibility Criteria - NCT02923466 *This information has been extracted from " www.clinicaltrials.gov"

  • 20190762 - Penedo Frank

  • Investigator:
    Frank Penedo
    RCname Email

    		Coordinator:

    IRB: 20190762

    		SDG: Population Sciences
    Disease Site(s):

    Lip, Oral Cavity and Pharynx,Esophagus,Breast,Cervix Uteri,Corpus Uteri,Ovary,Other Female Genital,Prostate,Other Male Genital,Bladder,Kidney,Other Urinary,Thyroid,Other Endocrine System,Stomach,Small Intestine,Colon,Rectum,Anus,Liver,Pancreas,Other Digestive Organ,Larynx,Lung,Other Respiratory and Intrathoracic Organs,Bones and Joints,Soft Tissue,Melanoma, skin,Kaposis sarcoma
    Sponsor: SCCC

    Enrolling Sites:

    Sylvester
    Title:

    Development of an eHealth-based Cognitive Behavioral Stress and Self-Management Intervention to Reduce Symptom Burden in HIV+ Gay and Bisexual MSM Treated for Non-Metastatic Cancer
    Eligibility Criteria - NCT04544917 *This information has been extracted from " www.clinicaltrials.gov"

  • AMC- 096 - Ramos, Juan Carlos

  • Investigator:
    Juan Carlos Ramos
    RCname Email

    		Coordinator:
    RCemailImg Sarah Lam
    RCphone +1 (305) 2438143

    IRB: 20180804

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Kaposis sarcoma
    Sponsor: AMC

    Enrolling Sites:

    Sylvester
    Title:

    AMC-096: A Phase II Study of sEphB4-HSA in Kaposi Sarcoma
    Eligibility Criteria - NCT02799485 *This information has been extracted from " www.clinicaltrials.gov"

  • AMC 098 - Ramos, Juan Carlos

  • Investigator:
    Juan Carlos Ramos
    RCname Email

    		Coordinator:
    RCemailImg Sarah Lam
    RCphone +1 (305) 2438143

    IRB: 20180856

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Kaposis sarcoma
    Sponsor: AMC

    Enrolling Sites:

    Sylvester
    Title:

    AMC-098:A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
    Eligibility Criteria - NCT03077451 *This information has been extracted from " www.clinicaltrials.gov"

  • Anlotinib AL3818-US-004A - Trent, Jonathan

  • Investigator:
    Jonathan Trent
    RCname Email

    		Coordinator:
    RCemailImg Mirna Gonzalez
    RCphone +1 (305) 2432441

    IRB: 20170072

    		SDG: Bone and Soft Tissue Cancers
    Disease Site(s):

    Soft Tissue
    Sponsor: ADVENCHEN LABORATORIES

    Enrolling Sites:

    Sylvester
    Title:

    AL3818-US-004A: Phase III Study of AL3818 (Anlotinib) HydrochlorideMonotherapy in Subjects with Metastatic or AdvancedAlveolar Soft Part Sarcoma, Leiomyosarcoma and SynovialSarcoma
    Eligibility Criteria - NCT03016819 *This information has been extracted from " www.clinicaltrials.gov"